CoChat

Scopolamine nasal spray in motion sickness: a randomised, controlled, and crossover study for the comparison of two scopolamine nasal sprays with oral dimenhydrinate and placebo

Klöcker, Norbert, Hanschke, Wolfgang, Toussaint, Susanne, Verse, Thomas · 2001 · European Journal of Pharmaceutical Sciences

The DOI matches its Crossref record; 23 of the 24 references it cites were found in a registry or an index.

Abstract

Scopolamine has been used successfully for treatment of motion sickness for almost a century and the nasal administration was first studied 50 years ago. However, there never appeared a nasal dosage form. Finally, after finding a stable and suitable formulation for scopolamine, a study to investigate efficacy, safety, and tolerability was conducted, with a randomised, double-blind, double-dummy, crossover, Latin square design including placebo control and a placebo/placebo control for internal validity at the German Air Force Institute of Aviation Medicine. To assess the efficacy of a new, stable and well-tolerated formulation of scopolamine nasal spray the reproducible induction of whole body vibrations by a rotating chair was chosen and a validated seasickness score (SKS). The reduction of SKS showed that scopolamine nasal spray at a concentration of 0.2% was statistically superior to both placebo and dimenhydrinate (P=0.003 and 0.004, respectively). There were no signs for a nasal or epipharyngeal irritation of the mucous membrane. Scopolamine nasal spray was found to be an effective and safe treatment in motion sickness, with a fast onset of action within 30 min after administration.

Overview

Integrity signals

Registry

Crossref · 10.1016/s0928-0987(01)00107-5

Cites

23 of 23 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 23 references

Cited by

See all 33

Metadata

Authors
Klöcker, N., Hanschke, W., Toussaint, S., & Verse, T.
Affiliations
  • Klinikum Frankfurt Höchst (DE)
  • Universität Ulm (DE)
Corresponding author
Klöcker, Norbert
Venue
European Journal of Pharmaceutical Sciences
Publisher
Elsevier BV
Published
2001-05
Volume
13
Issue
2
Pages
227-232
ISSN
0928-0987 (ISSN-L)
OpenAlex
W2047033263
Cited by
33
References
24
Citations by year
2024: 1 · 2023: 1 · 2022: 3 · 2020: 1 · 2019: 1 · 2018: 2 · 2017: 1 · 2015: 1 · 2014: 4 · 2013: 1 · 2012: 2
FWCI
1.32
Type
journal article
Language
en
Open access
closed
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations
  • European Journal of Pharmaceutical Sciences (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Surgery › Nausea and vomiting management
  • Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Advanced Drug Delivery Systems
  • Life Sciences › Neuroscience › Neurology › Vestibular and auditory disorders
Keywords
scopolamine, nasal spray, motion sickness, seasickness, dimenhydrinate, antiemetic efficacy, drug stability, tolerability, onset of action, whole-body vibration
MeSH terms
Administration, Inhalation, Adolescent, Adult, Aged, Antiemetics, Dimenhydrinate, Female, Humans, Male, Middle Aged, Motion Sickness, Scopolamine, Treatment Outcome, Cross-Over Studies, Muscarinic Antagonists

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Scopolamine nasal spray in motion sickness: a randomised, controlled, and crossover study for the comparison of two scopolamine nasal sprays with oral dimenhydrinate and placebo. https://app.cochat.ai/papers/10.1016/s0928-0987(01)00107-5
The paper
Klöcker, N., Hanschke, W., Toussaint, S., & Verse, T. (2001). Scopolamine nasal spray in motion sickness: a randomised, controlled, and crossover study for the comparison of two scopolamine nasal sprays with oral dimenhydrinate and placebo. European Journal of Pharmaceutical Sciences. https://doi.org/10.1016/s0928-0987(01)00107-5

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.